Faster access than browser!
13 relations: Aquaretic, ATC code C03, Autosomal dominant polycystic kidney disease, Cardiorenal syndrome, Demeclocycline, Diuretic, Hypotonic hyponatremia, Management of heart failure, Syndrome of inappropriate antidiuretic hormone secretion, Vasopressin, Vasopressin receptor, Vasopressin receptor 2, Vasopressin receptor antagonist.
Aquaretic
An aquaretic is a class of drug that is used to promote aquaresis, the excretion of water without electrolyte loss.
New!!: Tolvaptan and Aquaretic · See more »
ATC code C03
C03.
New!!: Tolvaptan and ATC code C03 · See more »
Autosomal dominant polycystic kidney disease
Autosomal dominant polycystic kidney disease (ADPKD) is the most prevalent, potentially lethal, monogenic human disorder.
New!!: Tolvaptan and Autosomal dominant polycystic kidney disease · See more »
Cardiorenal syndrome
Cardiorenal syndrome (CRS) is an umbrella term used in the medical field that defines disorders of the heart and kidneys whereby “acute or chronic dysfunction in one organ may induce acute or chronic dysfunction of the other”.
New!!: Tolvaptan and Cardiorenal syndrome · See more »
Demeclocycline
Demeclocycline (INN, BAN, USAN) (brand names Declomycin, Declostatin, Ledermycin, Bioterciclin, Deganol, Deteclo), also known under the brand names Detravis, Meciclin, Mexocine, Clortetrin, is a semisynthetic tetracycline antibiotic which was derived from a strain of Streptomyces aureofaciens.
New!!: Tolvaptan and Demeclocycline · See more »
Diuretic
A diuretic is any substance that promotes diuresis, the increased production of urine.
New!!: Tolvaptan and Diuretic · See more »
Hypotonic hyponatremia
Hypoosmolar hyponatremia is a condition where hyponatremia associated with a low plasma osmolality.
New!!: Tolvaptan and Hypotonic hyponatremia · See more »
Management of heart failure
Management of heart failure requires a multimodal approach.
New!!: Tolvaptan and Management of heart failure · See more »
Syndrome of inappropriate antidiuretic hormone secretion
Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is characterized by excessive unsuppressible release of antidiuretic hormone (ADH) either from the posterior pituitary gland, or an abnormal non-pituitary source.
New!!: Tolvaptan and Syndrome of inappropriate antidiuretic hormone secretion · See more »
Vasopressin
Vasopressin, also named antidiuretic hormone (ADH), arginine vasopressin (AVP) or argipressin, is a hormone synthesized as a peptide prohormone in neurons in the hypothalamus, and is converted to AVP.
New!!: Tolvaptan and Vasopressin · See more »
Vasopressin receptor
The actions of vasopressin are mediated by stimulation of tissue-specific G protein-coupled receptors (GPCRs) called vasopressin receptors that are classified into the V1 (V1A), V2, and V3 (V1B) receptor subtypes.
New!!: Tolvaptan and Vasopressin receptor · See more »
Vasopressin receptor 2
Vasopressin receptor 2 (V2R), or arginine vasopressin receptor 2 (officially called AVPR2), is a protein that acts as receptor for vasopressin.
New!!: Tolvaptan and Vasopressin receptor 2 · See more »
Vasopressin receptor antagonist
A vasopressin receptor antagonist (VRA) is an agent that interferes with action at the vasopressin receptors.
New!!: Tolvaptan and Vasopressin receptor antagonist · See more »
Redirects here:
ATC code C03XA01, ATCvet code QC03XA01, C26H25ClN2O3, Jinarc, Samsca.
